Cargando…

Acute heart failure due to autoimmune myocarditis under pembrolizumab treatment for metastatic melanoma

Antibodies that stimulate the immune system by targeting inhibitory T cell receptors were successfully introduced into oncological practice and are capable to overcome tumor-induced immune evasion. In particular, targeting of the inhibitory receptors CTLA-4 and PD-1 or its ligand PD-L1 have been sho...

Descripción completa

Detalles Bibliográficos
Autores principales:	Läubli, Heinz, Balmelli, Cathrin, Bossard, Matthias, Pfister, Otmar, Glatz, Kathrin, Zippelius, Alfred
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4404586/ https://www.ncbi.nlm.nih.gov/pubmed/25901283 http://dx.doi.org/10.1186/s40425-015-0057-1

Ejemplares similares

Pembrolizumab-induced optic neuropathy – a case report
por: Daetwyler, Eveline, et al.
Publicado: (2023)

Disease stabilization with pembrolizumab for metastatic acral melanoma in the setting of autoimmune bullous pemphigoid
por: Beck, Kristen M., et al.
Publicado: (2016)

Changes of peripheral T cell subsets in melanoma patients with immune-related adverse events
por: Müller, Benjamin, et al.
Publicado: (2023)

Tumor-associated carbohydrates and immunomodulatory lectins as targets for cancer immunotherapy
por: Rodrigues Mantuano, Natalia, et al.
Publicado: (2020)

Cerebral vasculitis mimicking intracranial metastatic progression of lung cancer during PD-1 blockade
por: Läubli, Heinz, et al.
Publicado: (2017)

Pembrolizumab: First in Class for Treatment of Metastatic Melanoma
por: Barnhart, Carrie
Publicado: (2015)

Pembrolizumab and tavokinogene telseplasmid electroporation in metastatic melanoma
por: Dollin, Yonatan, et al.
Publicado: (2020)

Treatment of mycophenolate-resistant immune-related organizing pneumonia with infliximab
por: Ortega Sanchez, Guacimara, et al.
Publicado: (2018)

Steroid-Refractory Autoimmune Myocarditis after Pembrolizumab Therapy: Failure of Equine Anti-Thymocyte Globulin to Prevent Heart Failure
por: Baclig, NV, et al.
Publicado: (2019)

Influenza vaccination of cancer patients during PD-1 blockade induces serological protection but may raise the risk for immune-related adverse events
por: Läubli, Heinz, et al.
Publicado: (2018)

SAT-661 The Lesser Evil: Pembrolizumab Induced Remission of Metastatic Melanoma with Autoimmune Diabetes, Hypothyroidism, and Colitis
por: Harris, Asaf, et al.
Publicado: (2020)

Pembrolizumab as first-line treatment for metastatic uveal melanoma
por: Rossi, Ernesto, et al.
Publicado: (2019)

Disseminated blastomycosis in a patient on pembrolizumab for metastatic melanoma
por: Ferguson, Ian, et al.
Publicado: (2019)

Tumoral Melanosis Associated with Pembrolizumab-Treated Metastatic Melanoma
por: Bari, Omar, et al.
Publicado: (2017)

Autoimmune inner ear disease in a melanoma patient treated with pembrolizumab
por: Zibelman, Matthew, et al.
Publicado: (2016)

A different type of acute myocarditis: a case report of acute autoimmune myocarditis mediated by anti-PD-1 T lymphocyte receptor (pembrolizumab)
por: Salido Iniesta, Mario, et al.
Publicado: (2020)

Lichen planopilaris associated with pembrolizumab in a patient with metastatic melanoma
por: Cogen, Anna L., et al.
Publicado: (2018)

Efficacy of pembrolizumab for advanced/metastatic melanoma: a meta-analysis
por: Zhang, Qi, et al.
Publicado: (2020)

Pembrolizumab-Induced Fatal Myasthenia, Myocarditis, and Myositis in a Patient with Metastatic Melanoma: Autopsy, Histological, and Immunohistochemical Findings—A Case Report and Literature Review
por: Giovannini, Elena, et al.
Publicado: (2023)

Predicting response to pembrolizumab in metastatic melanoma by a new personalization algorithm
por: Tsur, Neta, et al.
Publicado: (2019)

Durable Response with Single-Agent Pembrolizumab in a Patient with Metastatic Melanoma
por: Cyriac, Sanju, et al.
Publicado: (2021)

Simultaneous pembrolizumab-induced myasthenia gravis and myocarditis in a patient with metastatic bladder cancer: A case report
por: Takai, Manabu, et al.
Publicado: (2020)

Loss of Lymphotoxin Alpha-Expressing Memory B Cells Correlates with Metastasis of Human Primary Melanoma
por: Werner, Franziska, et al.
Publicado: (2021)

A Standardized Analysis of Tertiary Lymphoid Structures in Human Melanoma: Disease Progression- and Tumor Site-Associated Changes With Germinal Center Alteration
por: Werner, Franziska, et al.
Publicado: (2021)

Pembrolizumab-Induced Myocarditis and Delayed Acute Inflammatory Demyelinating Polyradiculoneuropathy
por: Dalal, Fazal, et al.
Publicado: (2022)

Case report: Electrocardiographic changes in pembrolizumab-induced fatal myocarditis
por: Nishiyama, Kazuhiro, et al.
Publicado: (2023)

AIHA and Pancytopenia as Complications of Pembrolizumab Therapy for Metastatic Melanoma: A Case Report
por: Ni, Dan, et al.
Publicado: (2019)

The PEMDAC phase 2 study of pembrolizumab and entinostat in patients with metastatic uveal melanoma
por: Ny, Lars, et al.
Publicado: (2021)

Overall survival in metastatic melanoma correlates with pembrolizumab exposure and T cell exhaustion markers
por: Navani, Vishal, et al.
Publicado: (2021)

Phase I trial of pembrolizumab plus vemurafenib and cobimetinib in patients with metastatic melanoma
por: Shaikh, Saba S., et al.
Publicado: (2022)

Myocarditis Induced by Immunotherapy in Metastatic Melanoma—Review of Literature and Current Guidelines
por: Czarnecka, Anna M., et al.
Publicado: (2022)

Fulminant hepatic failure due to metastatic choroidal melanoma
por: Escobar-Valdivia, Emmanuel, et al.
Publicado: (2017)

Organizing pneumonia following treatment with pembrolizumab for metastatic malignant melanoma – A case report
por: Kuint, R., et al.
Publicado: (2017)

Cutaneous CD56(+) T-cell lymphoma developing during pembrolizumab treatment for metastatic melanoma
por: Zheng, Yixuan James, et al.
Publicado: (2018)

A case of pembrolizumab-induced severe DKA and hypothyroidism in a patient with metastatic melanoma
por: Hakami, Osamah A, et al.
Publicado: (2019)

Metastatic melanoma with features of blue nevus and tumoral melanosis identified during pembrolizumab therapy
por: Helm, Matthew F., et al.
Publicado: (2017)

Pembrolizumab-Induced Psoriasis in Metastatic Melanoma: Activity and Safety of Apremilast, a Case Report
por: Siciliano, Maria Anna, et al.
Publicado: (2020)

Autoimmune Myasthenia, Primary Adrenal Insufficiency, and Progressive Hypothyroidism Due to Pembrolizumab and Axitinib Combination Regimen
por: Figueroa-Perez, Nikole, et al.
Publicado: (2021)

Utile or futile: biomarkers in the ICU
por: Balmelli, Cathrin, et al.
Publicado: (2011)

Effects of COVID-19 Lockdown on Melanoma Diagnosis in Switzerland: Increased Tumor Thickness in Elderly Females and Shift towards Stage IV Melanoma during Lockdown
por: Kostner, Lisa, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_h747l3al9ndue2j2iemflpjodj